Bank of New York Mellon
BRLI

Bank of New York Mellon’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bank of New York Mellon’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-412,373
Closed -$17M – 4447
2015
Q2 		$17M Sell
412,373
-93,588
-18% -$3.36M ﹤0.01% 1593
2015
Q1 		$17.8M Buy
505,961
+171,490
+51% +$5.8M ﹤0.01% 1592
2014
Q4 		$10.7M Sell
334,471
-10,706
-3% -$310K ﹤0.01% 1869
2014
Q3 		$9.69M Buy
345,177
+9,552
+3% +$291K ﹤0.01% 1909
2014
Q2 		$10.1M Sell
335,625
-4,032
-1% -$111K ﹤0.01% 1925
2014
Q1 		$9.4M Sell
339,657
-86,779
-20% -$2.27M ﹤0.01% 1938
2013
Q4 		$10.9M Buy
426,436
+18,648
+5% +$575K ﹤0.01% 1843
2013
Q3 		$12.2M Sell
407,788
-59,789
-13% -$1.66M ﹤0.01% 1723
2013
Q2 		$13.4M Buy
+467,577
New +$12.9M ﹤0.01% 1620

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Bank of New York Mellon's BRLI Position: Q3 2015 in Review

Bank of New York Mellon sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 412,373 shares — an estimated $17M sold.

Bank of New York Mellon first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $17.8M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Bank of New York Mellon reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 412,373 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $17M.
  • Bank of New York Mellon first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Bank of New York Mellon's BIO-REFERENCE LABS INC-NEW- position peaked at $17.8M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Bank of New York Mellon's 13F filing for Q3 2015, filed 10 Nov 2015.